| ALK | anaplastic lymphoma kinase |
| BOC | tert-butyloxycarbonyl-protecting group |
| CLSM | confocal laser scanning microscopy |
| c-Met | hepatocyte growth factor receptor |
| COMU | (1-Cyano-2-ethoxy-2-oxoethylidenaminooxy)dimethylamino-morpholino-carbenium hexafluorophosphate |
| crizotinib | (R)-crizotinib, (Xalkori®, Pfizer) |
| crizotinib* | racemic mixture of (R)-crizotinib and (S)-crizotinib |
| EMEM | Eagle’s minimum essential medium |
| FBS | Fetal bovine serum |
| fibroblast cells | human primary human skin fibroblast cells |
| galectin-1 | lectin galactoside binding soluble 1 |
| galectin-3 | lectin galactoside binding soluble 3 |
| HRMS | high resolution mass spectrometry |
| LMP | lysosomal membrane permeabilization |
| MJ55* | racemic mixture of (R)-MJ55 and (S)-MJ55 |
| NSCLC | non-small cell lung cancer |
| Pd(dppf)Cl2 | [1,1′-Bis(diphenylphosphino)ferrocene]dichloropalladium(II) |
| ROS-1 | ROS proto-oncogene 1, receptor tyrosine kinase |
| RTK | receptor tyrosine kinase |
| SD | standard deviation |
| TEA | triethylamine |
| TFEB | transcription factor EB |
| THF | tetrahydrofuran |